Sweden · Master's
Karolinska Institutet
MSc Biomedicine
Karolinska Institutet
Course Overview
Karolinska Institutet's MSc Biomedicine is the flagship 2-year biomedical research Master's at the world's #1 medical university (QS Medicine 2024). The programme is designed to produce graduates capable of leading laboratory-based biomedical research — with substantial wet-lab training, two extensive research project semesters, and the option to specialise across molecular medicine, cell biology, immunology and infection biology, neuroscience, regenerative medicine, and translational medicine. KI's research output sits in the top 5-10 globally for biomedical sciences (Shanghai Subject Rankings) and the alumni network feeds directly into AstraZeneca (HQ in Cambridge, but large Swedish operations), Octapharma, Novartis Sweden, Sandoz, plus the Karolinska University Hospital research environment.
Sri Lankan applicants — typically MBBS graduates seeking research credentials, BSc Biology / Biotechnology / Biochemistry / Microbiology graduates from Colombo / Peradeniya / Kelaniya / Sri Jayewardenepura / SLINTEC, plus BSc Pharmacy and Allied Health holders — choose KI Biomedicine for: the credibility of the world's #1 medical university, deep wet-lab research training (rare in Sri Lankan biomedical Bachelor's programmes), direct pipeline into KI PhD programmes (most KI PhDs are filled from MSc Biomedicine graduates), and Sweden's 12-month post-study residence permit. Tuition for non-EU students sits at ~SEK 275,000/year (LKR 8.8M/yr). The 4-semester programme bundles coursework (molecular biology, genetics, immunology, neuroscience, research methods) with two substantial research project semesters culminating in a Master's thesis. Sri Lankan returnees route into research scientist roles at SLINTEC, the Industrial Technology Institute (ITI), the Medical Research Institute (MRI), academic positions at the Faculties of Medicine Colombo / Peradeniya / Kelaniya, plus pharmaceutical / biotech industry roles at Hemas Pharmaceuticals, State Pharmaceuticals Corporation, and emerging Sri Lankan biotech ventures.
Entry Requirements
Academic
- check_circle Bachelor's degree (180 ECTS) in Biomedicine, Medicine (MBBS), Biology, Biotechnology, Biochemistry, Molecular Biology, Pharmacy, or a closely-related life-sciences discipline with first / upper-second class equivalent.
- check_circle Demonstrated coursework in molecular biology, biochemistry, cell biology, and genetics — KI runs a strict curriculum-equivalence check (the strongest Sri Lankan candidates have completed at least 60 ECTS-equivalent in molecular biosciences).
- check_circle Sri Lankan applicants from MBBS at SLMC-recognised faculties, BSc Biology / Biotechnology / Biochemistry / Microbiology / Molecular Biology at Colombo / Peradeniya / Kelaniya / Sri Jayewardenepura / Wayamba / Uva Wellassa, plus BSc Pharmacy / Allied Health, are competitive.
- check_circle Motivation letter (1-2 pages on biomedical research career objectives), CV with any prior research experience, 2 academic references, and transcripts uploaded to universityadmissions.se.
- check_circle Application via universityadmissions.se — applications open mid-October, deadline January 15, application fee SEK 900.
English Proficiency
- check_circle IELTS Academic: 6.5 Overall (no band below 5.5) — Swedish 'English 6' equivalent.
- check_circle TOEFL iBT: 90 Overall.
- check_circle Cambridge English: C1 Advanced.
- check_circle Programme is taught 100% in English — Swedish not required for the degree.
- check_circle Waived if your prior degree was taught entirely in English (Sri Lankan MBBS / BSc holders from recognised faculties qualify with an MOI letter).
Estimated Cost of Study
| Expense Category | Amount (SEK) | Approx. LKR |
|---|---|---|
| Tuition Fee (per year, non-EU) | SEK 275,000 | Rs. 8,800,000 |
| Living Expenses in Stockholm (12 months) | SEK 130,000 | Rs. 4,160,000 |
| Student Visa, Residence Permit & Health Insurance | SEK 14,000 | Rs. 448,000 |
| Lab Materials, Books & Conference Travel | SEK 15,000 | Rs. 480,000 |
| Total Year 1 Investment | SEK 434,000 | Rs. 13,888,000 |
*LKR conversion based on current bank rates. Subject to change.
Career Outcomes & PR
Karolinska MSc Biomedicine graduates qualify for Sweden's 12-month post-study residence permit to job-search, with conversion to a work permit (or EU Blue Card) at a qualifying offer. Major employers: AstraZeneca Sweden, Octapharma, Novartis Sweden, Sandoz, Pfizer Stockholm, plus the Karolinska University Hospital research environment, the Stockholm region's biotech ecosystem (BioStock-listed companies, the Karolinska Institutet Holding spinouts), and academic research positions at Swedish universities. Most graduates continue to PhD programmes (KI has the largest PhD intake in Sweden). Median starting research scientist salary SEK 38,000-SEK 50,000/month. Sri Lankan returnees route into research scientist roles at SLINTEC, the Industrial Technology Institute (ITI), the Medical Research Institute (MRI), academic positions at the Faculties of Medicine Colombo / Peradeniya / Kelaniya, plus pharmaceutical / biotech industry roles at Hemas Pharmaceuticals, State Pharmaceuticals Corporation, and emerging Sri Lankan biotech.
Related Programs
Ready to Start Your Journey?
Our counsellors have helped hundreds of Sri Lankan students secure placements in Sweden. We handle everything from applications to visa processing.
ඔබට සුදුසු විශ්වවිද්යාලයක් තේරීම, අයදුම්පත් යොමු කිරීම, SOP සකස් කිරීම සහ වීසා ලබා ගැනීම ඇතුළු සෑම පියවරකදීම, ඔබ වෙනුවෙන් සියලුම වගකීම් විශ්වාසවන්තව අප භාර ගනිමු.